Schonfeld Strategic Advisors LLC Ab Cellera Biologics Inc. Transaction History

Schonfeld Strategic Advisors LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$4.6 - $7.95 $970,599 - $1.68 Million	211,000 Added 143.15%	358,400 $1.65 Million
Q2 2023 Aug 14, 2023	BUY	$5.66 - $7.59 $370,730 - $497,145	65,500 Added 79.98%	147,400 $952,000
Q1 2023 May 15, 2023	SELL	$7.31 - $11.18 $532,899 - $815,022	-72,900 Reduced 47.09%	81,900 $617,000
Q4 2022 Feb 14, 2023	SELL	$9.48 - $14.52 $643,692 - $985,908	-67,900 Reduced 30.49%	154,800 $1.57 Million
Q3 2022 Nov 14, 2022	BUY	$9.2 - $13.68 $776,479 - $1.15 Million	84,400 Added 61.03%	222,700 $2.2 Million
Q2 2022 Aug 15, 2022	BUY	$5.72 - $10.65 $82,368 - $153,360	14,400 Added 11.62%	138,300 $1.47 Million
Q1 2022 May 16, 2022	BUY	$7.46 - $14.14 $924,294 - $1.75 Million	123,900 New	123,900 $1.21 Million
Q4 2021 Feb 14, 2022	SELL	$12.99 - $17.73 $747,444 - $1.02 Million	-57,540 Closed	0 $0
Q3 2021 Nov 16, 2021	BUY	$14.85 - $21.34 $854,469 - $1.23 Million	57,540 New	57,540 $1.15 Million

153

109M

153K

194K

Ticker ABCL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 285,139,008
Market Cap $787M
Description
AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...

Get notified when there are updates to the investment portfolio of Schonfeld Strategic Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Schonfeld Strategic Advisors LLC with notifications on news.